相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Toll-Like Receptors, Infections, and Rheumatoid Arthritis
Marina Arleevskaya et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
The Innate Part of the Adaptive Immune System
Sophie Hillion et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjogren's Syndrome
Amandine Charras et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjogren's syndrome in the JOQUER randomized trial
Iris L. A. Bodewes et al.
RHEUMATOLOGY (2020)
Exposure-Response Analyses of the Effects of Venetoclax, a Selective BCL-2 Inhibitor, on B-Lymphocyte and Total Lymphocyte Counts in Women with Systemic Lupus Erythematosus
Ahmed Nader et al.
CLINICAL PHARMACOKINETICS (2020)
Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects With Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis, or Atopic Dermatitis: Population Analyses of Phase 1 and 2 Clinical Trials
Ahmed Nader et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Methyltransferase Dot1l preferentially promotes innate IL-6 and IFN-beta production by mediating H3K79me2/3 methylation in macrophages
Xiang Chen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
IFN-alpha kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study
Frederic A. Houssiau et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Targeted Biologic Therapy for Systemic Lupus Erythematosus: Emerging Pathways and Drug Pipeline
Kalliopi Klavdianou et al.
BIODRUGS (2020)
Sjogren's syndrome: Old and new therapeutic targets
Clio P. Mavragani et al.
JOURNAL OF AUTOIMMUNITY (2020)
JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency
Fahad Alsohime et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Successful Trial for Lupus - How Good Is Good Enough?
Jane E. Salmon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
Eric F. Morand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
JAK Inhibitors: Prospects in Connective Tissue Diseases
Hanxiao You et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
Spebrutinib (CC-292) Affects Markers of B Cell Activation, Chemotaxis, and Osteoclasts in Patients with Rheumatoid Arthritis: Results from a Mechanistic Study
Peter H. Schafer et al.
RHEUMATOLOGY AND THERAPY (2020)
Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients
Mei Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis
Peter C. Taylor
RHEUMATOLOGY (2019)
Clinical efficacy of new JAK inhibitors under development. Just more of the same?
Rene Westhovens
RHEUMATOLOGY (2019)
JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
George E. Fragoulis et al.
RHEUMATOLOGY (2019)
Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis
Masayoshi Harigai
RHEUMATOLOGY (2019)
Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
Charalampia Papadopoulou et al.
BRAIN (2019)
SAMHD1 and the innate immune response to cytosolic DNA during DNA replication
Flavie Coquel et al.
CURRENT OPINION IN IMMUNOLOGY (2019)
Type I interferon dysregulation in Systemic Sclerosis
Brian Skaug et al.
CYTOKINE (2019)
Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus
Richard Furie et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Assessment of Clinical Response to Janus Kinase Inhibition in Patients With Familial Chilblain Lupus and TREX1 Mutation
Nick Zimmermann et al.
JAMA DERMATOLOGY (2019)
Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 update
Satoshi Kubo et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
Shared and Distinct Functions of Type I and Type III Interferons
Helen M. Lazear et al.
IMMUNITY (2019)
A Balancing Act: MDA5 in Antiviral Immunity and Autoinflammation
Antonio Gregorio Dias Junior et al.
TRENDS IN MICROBIOLOGY (2019)
Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN
Yannick Dieudonne et al.
JOURNAL OF AUTOIMMUNITY (2019)
Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models
Philipp Haselmayer et al.
JOURNAL OF IMMUNOLOGY (2019)
Tofacitinib Treatment of Refractory Systemic Juvenile Idiopathic Arthritis
Zhixiang Huang et al.
PEDIATRICS (2019)
Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan
Tsutomu Takeuchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Interferon-inducible cytoplasmic lncLrrc55-AS promotes antiviral innate responses by strengthening IRF3 phosphorylation
Yumei Zhou et al.
CELL RESEARCH (2019)
Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial
Mark C. Genovese et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Ultraviolet light induces increased T cell activation in lupus-prone mice via type I IFN-dependent inhibition of T regulatory cells
Sonya J. Wolf et al.
JOURNAL OF AUTOIMMUNITY (2019)
Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5
Morgan Brisse et al.
FRONTIERS IN IMMUNOLOGY (2019)
Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
I-Tsu Chyuan et al.
CELLS (2019)
Autoreactive B cells in SLE, villains or innocent bystanders?
Jennie A. Hamilton et al.
IMMUNOLOGICAL REVIEWS (2019)
Interferon target-gene expression and epigenomic signatures in health and disease
Franck J. Barrat et al.
NATURE IMMUNOLOGY (2019)
Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency
Coralie Briand et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Rheumatoid arthritis-associated DNA methylation sites in peripheral blood mononuclear cells
Hong Zhu et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Systemic lupus erythematosus: Diagnosis and clinical management
Andrea Fava et al.
JOURNAL OF AUTOIMMUNITY (2019)
Systemic features of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a monogenic small vessel disease
N. Pelzer et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib
Siamak Moghadam-Kia et al.
RHEUMATOLOGY (2019)
Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features
Gian Marco Moneta et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi-Goutieres Syndrome, a Type I Interferonopathy
Kornvalee Meesilpavikkai et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Interferon-α enhances the IL-12-induced STAT4 activation selectively in carriers of the STAT4 SLE risk allele rs7574865[T]
Niklas Hagberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Sex Differences in Pediatric Rheumatology
Marco Cattalini et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2019)
Safety and pharmacodynamics of venetoclax (ABT-199) in a randomized single and multiple ascending dose study in women with systemic lupus erythematosus
P. Lu et al.
LUPUS (2018)
The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family
Hideo Negishi et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Myogenic Progenitor Cells Exhibit Type I Interferon-Driven Proangiogenic Properties and Molecular Signature During Juvenile Dermatomyositis
Cyril Gitiaux et al.
ARTHRITIS & RHEUMATOLOGY (2018)
DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus
Juliana Imgenberg-Kreuz et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab
Eric F. Morand et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE
Niklas Hagberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus
Yasuhiro Kato et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa
Mrinal K. Sarkar et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Targeting interferons and their pathways in systemic lupus erythematosus
Francois Chasset et al.
AUTOIMMUNITY REVIEWS (2018)
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis
Leandro Ladislau et al.
BRAIN (2018)
H5N1 influenza virus-specific miRNA-like small RNA increases cytokine production and mouse mortality via targeting poly(rC)-binding protein 2
Xihan Li et al.
CELL RESEARCH (2018)
Extracellular DNA and autoimmune diseases
Hantao Lou et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
TBK1: A key regulator and potential treatment target for interferon positive Sjogren's syndrome, systemic lupus erythematosus and systemic sclerosis
Iris L. A. Bodewes et al.
JOURNAL OF AUTOIMMUNITY (2018)
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
Gina A. Montealegre Sanchez et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
JAK inhibitors in autoinflammation
Hal M. Hoffman et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Genome-Wide DNA Methylation Analysis in Systemic Sclerosis Reveals Hypomethylation of IFN-Associated Genes in CD4(+) and CD8(+) T Cells
Weifeng Ding et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Cyclin-dependent kinase activity is required for type I interferon production
Oya Cingoz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8
Marie Dominique Ah Kioon et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Therapeutic Perspectives for Interferons and Plasmacytoid Dendritic Cells in Rheumatoid Arthritis
Ramzi Nehmar et al.
TRENDS IN MOLECULAR MEDICINE (2018)
Translational Biomarkers and Ex Vivo Models of Joint Tissues as a Tool for Drug Development in Rheumatoid Arthritis
Cecilie F. Kjelgaard-Petersen et al.
ARTHRITIS & RHEUMATOLOGY (2018)
JAK-1 Inhibition Suppresses Interferon-Induced BAFF Production in Human Salivary Gland Potential Therapeutic Strategy for Primary Sjogren's Syndrome
Jaeseon Lee et al.
ARTHRITIS & RHEUMATOLOGY (2018)
TRIM Proteins and Their Roles in Antiviral Host Defenses
Michiel van Gent et al.
ANNUAL REVIEW OF VIROLOGY, VOL 5 (2018)
CD19+CD24hiCD38hi B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-α
Christopher J. M. Piper et al.
FRONTIERS IN IMMUNOLOGY (2018)
Insights Gained From the Study of Pediatric Systemic Lupus Erythematosus
Mindy S. Lo
FRONTIERS IN IMMUNOLOGY (2018)
The role of the JAK/STAT signal pathway in rheumatoid arthritis
Charles J. Malemud
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2018)
HDAC stimulates gene expression through BRD4 availability in response to IFN and in interferonopathies
Isabelle J. Marie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
IFIT1 Exerts Opposing Regulatory Effects on the Inflammatory and Interferon Gene Programs in LPS-Activated Human Macrophages
Sinu P. John et al.
CELL REPORTS (2018)
Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?
M. Javad Wahadat et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus
Jyoti Bakshi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)
Familial chilblain lupus due to a gain-of-function mutation in STING
Nadja Konig et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Claudia Bracaglia et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease
Gillian I. Rice et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2017)
Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity
Shailesh Dudhgaonkar et al.
JOURNAL OF IMMUNOLOGY (2017)
Investigational drugs for treatment of juvenile idiopathic arthritis
Angela Mauro et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE
Siobhan Smith et al.
JOURNAL OF AUTOIMMUNITY (2017)
Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review
Kun Chen et al.
JOURNAL OF AUTOIMMUNITY (2017)
The molecular basis for differential type I interferon signaling
Gideon Schreiber
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The emerging safety profile of JAK inhibitors in rheumatic disease
Kevin L. Winthrop
NATURE REVIEWS RHEUMATOLOGY (2017)
STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling
Kei-ichiro Arimoto et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study
Nicolino Ruperto et al.
PEDIATRIC RHEUMATOLOGY (2017)
Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy
Antonios Psarras et al.
RHEUMATOLOGY (2017)
Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus
Laurie S. Davis et al.
RHEUMATOLOGY (2017)
Future therapeutic targets in rheumatoid arthritis?
Tommy Tsang Cheung et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Crosstalk between Cytoplasmic RIG-I and STING Sensing Pathways
Alessandra Zevini et al.
TRENDS IN IMMUNOLOGY (2017)
IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP
K. L. Jonsson et al.
NATURE COMMUNICATIONS (2017)
STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling
Kei-ichiro Arimoto et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Association of MicroRNA-618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis
Marzia Rossato et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis
Mark C. Genovese et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
Richard Furie et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Monogenic lupus: it's all new!
Patricia Costa-Reis et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity
Kun Chen et al.
CELL (2017)
Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathway
Nicola Raftery et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-alpha) in patients with systemic lupus erythematosus (ROSE)
Kenneth C. Kalunian et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
CANDLE syndrome: chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature-a rare case with a novel mutation
Miria Paula V. Cavalcante et al.
EUROPEAN JOURNAL OF PEDIATRICS (2016)
Sumoylation coordinates the repression of inflammatory and anti-viral gene-expression programs during innate sensing
Adrien Decque et al.
NATURE IMMUNOLOGY (2016)
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
Munther Khamashta et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Genome-wide DNA methylation analysis in multiple tissues in primary Sjogren's syndrome reveals regulatory effects at interferon-induced genes
Juliana Imgenberg-Kreuz et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Autoimmune regulator and self-tolerance - molecular and clinical aspects
Jakub Abramson et al.
IMMUNOLOGICAL REVIEWS (2016)
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children
Marie-Louise Fremond et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Rb selectively inhibits innate IFN-β production by enhancing deacetylation of IFN-β promoter through HDACI and HDAC8
Jun Meng et al.
JOURNAL OF AUTOIMMUNITY (2016)
Long noncoding RNA #32 contributes to antiviral responses by controlling interferon-stimulated gene expression
Hironori Nishitsuji et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study
Julie Ducreux et al.
RHEUMATOLOGY (2016)
miR-203 and miR-221 regulate SOCS1 and SOCS3 in essential thrombocythemia
A. Navarro et al.
BLOOD CANCER JOURNAL (2016)
MicroRNA-130b Ameliorates Murine Lupus Nephritis Through Targeting the Type I Interferon Pathway on Renal Mesangial Cells
Xiao Han et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Development of rheumatoid arthritis during treatment of multiple sclerosis with interferon beta 1-a. Coincidence of two conditions or a complication of treatment: A case report
Seyed Mohammad Masood Hojjati et al.
JOURNAL OF ADVANCED RESEARCH (2016)
The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA
Annie Yarwood et al.
RHEUMATOLOGY (2016)
Global functional profiling of human ubiquitome identifies E3 ubiquitin ligase DCST1 as a novel negative regulator of Type-I interferon signaling
Sajith Nair et al.
SCIENTIFIC REPORTS (2016)
Mutations in DDX58, which Encodes RIG-I, Cause Atypical Singleton-Merten Syndrome
Mi-Ae Jang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
A Specific IFIH1 Gain-of-Function Mutation Causes Singleton-Merten Syndrome
Frank Rutsch et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2015)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
Type I interferonopathies: Mendelian type I interferon up-regulation
Yanick J. Crow
CURRENT OPINION IN IMMUNOLOGY (2015)
Role of type I interferon in inducing a protective immune response: Perspectives for clinical applications
Paola Rizza et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Immunogenetics of systemic lupus erythematosus: A comprehensive review
Yogita Ghodke-Puranik et al.
JOURNAL OF AUTOIMMUNITY (2015)
Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production
Anja Brehm et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Suppression of T Cell Activation and Collagen Accumulation by an Anti-IFNAR1 mAb, Anifrolumab, in Adult Patients with Systemic Sclerosis
Xiang Guo et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C protease to enhance interferon signaling and control viral infection
Yong Zhang et al.
NATURE IMMUNOLOGY (2015)
Type I interferonopathies-an expanding disease spectrum of immunodysregulation
Min Ae Lee-Kirsch et al.
SEMINARS IN IMMUNOPATHOLOGY (2015)
Bcl-2 Antagonists Kill Plasmacytoid Dendritic Cells From Lupus-Prone Mice and Dampen Interferon-α Production
Yifan Zhan et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Aicardi-Goutieres Syndrome Is Caused by IFIH1 Mutations
Hirotsugu Oda et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2014)
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-alpha monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
Brandon W. Higgs et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Genome-wide association studies in Sjogren's syndrome: What do the genes tell us about disease pathogenesis?
Peter D. Burbelo et al.
AUTOIMMUNITY REVIEWS (2014)
Toll-Like Receptors in Antiviral Innate Immunity
Sandra N. Lester et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Interferon-Inducible Protein IFI35 Negatively Regulates RIG-I Antiviral Signaling and Supports Vesicular Stomatitis Virus Replication
Anshuman Das et al.
JOURNAL OF VIROLOGY (2014)
PTPN22: the archetypal non-HLA autoimmunity gene
Stephanie M. Stanford et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Activated STING in a Vascular and Pulmonary Syndrome
Y. Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Negative regulation of the interferon response by an interferon-induced long non-coding RNA
Hiroto Kambara et al.
NUCLEIC ACIDS RESEARCH (2014)
A20 in inflammation and autoimmunity
Leen Catrysse et al.
TRENDS IN IMMUNOLOGY (2014)
Dose-escalation of human anti-interferon-alpha receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study
Avram Goldberg et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon
Bing-Ching Ho et al.
NATURE COMMUNICATIONS (2014)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression
Zana Brkic et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
The type I IFN signature as a biomarker of preclinical rheumatoid arthritis
Joyce Luebbers et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis
Xiaochun Liu et al.
ARTHRITIS AND RHEUMATISM (2013)
Type I interferons in Sjogren's syndrome
Yihong Yao et al.
AUTOIMMUNITY REVIEWS (2013)
Type I Interferons: Beneficial in Th1 and Detrimental in Th17 Autoimmunity
Robert C. Axtell et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)
The Autoimmunity-Associated Gene PTPN22 Potentiates Toll-like Receptor-Driven, Type 1 Interferon-Dependent Immunity
Yaya Wang et al.
IMMUNITY (2013)
Association of interleukin-1 receptor-associated kinase (IRAK1) gene polymorphisms (rs3027898, rs1059702) with systemic lupus erythematosus in a Chinese Han population
Yu Zhai et al.
INFLAMMATION RESEARCH (2013)
Genetic susceptibility to SLE: Recent progress from GWAS
Yong Cui et al.
JOURNAL OF AUTOIMMUNITY (2013)
Negative Regulation of Nmi on Virus-Triggered Type I IFN Production by Targeting IRF7
Jie Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
Autoimmune Rheumatic Diseases 3 Immunopathogenic mechanisms of systemic autoimmune disease
Marie Wahren-Herlenius et al.
LANCET (2013)
Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis
Anne Hinks et al.
NATURE GENETICS (2013)
The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling
Donald T. Gracias et al.
NATURE IMMUNOLOGY (2013)
OASL1 inhibits translation of the type I interferon-regulating transcription factor IRF7
Myeong Sup Lee et al.
NATURE IMMUNOLOGY (2013)
Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases
Jing Li et al.
PHARMACOLOGY & THERAPEUTICS (2013)
A Short Hairpin RNA Screen of Interferon-Stimulated Genes Identifies a Novel Negative Regulator of the Cellular Antiviral Response
Jianqing Li et al.
MBIO (2013)
DDX24 Negatively Regulates Cytosolic RNA-Mediated Innate Immune Signaling
Zhe Ma et al.
PLOS PATHOGENS (2013)
HCV-Induced miR-21 Contributes to Evasion of Host Immune System by Targeting MyD88 and IRAK1
Yanni Chen et al.
PLOS PATHOGENS (2013)
Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives
Markus J. Seibel et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
The role of type 1 interferon in systemic sclerosis
Minghua Wu et al.
FRONTIERS IN IMMUNOLOGY (2013)
Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus Results of a phase I, placebo-controlled, double-blind, dose-escalation study
Jacqueline M. McBride et al.
ARTHRITIS AND RHEUMATISM (2012)
Adenovirus Evasion of Interferon-Mediated Innate Immunity by Direct Antagonism of a Cellular Histone Posttranslational Modification
G. J. Fonseca et al.
CELL HOST & MICROBE (2012)
MicroRNA-466l inhibits antiviral innate immune response by targeting interferon-alpha
Yingke Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
The genetics of type I interferon in systemic lupus erythematosus
Paola G. Bronson et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Janus-like effects of type I interferon in autoimmune diseases
Robert C. Axtell et al.
IMMUNOLOGICAL REVIEWS (2012)
Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways
Yuki Sugiyama et al.
INTERNATIONAL IMMUNOLOGY (2012)
TRAF-interacting protein (TRIP) negatively regulates IFN-β production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1
Meng Zhang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response
Terry C. Fang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature
Gillian I. Rice et al.
NATURE GENETICS (2012)
Emerging Role of Ubiquitination in Antiviral RIG-I Signaling
Jonathan Maelfait et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
Interferon regulatory factor 5 gene polymorphism confers risk to several rheumatic diseases and correlates with expression of alternative thymic transcripts
Gry B. N. Nordang et al.
RHEUMATOLOGY (2012)
Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE
Angela Midgley et al.
RHEUMATOLOGY (2012)
MicroRNAs and STAT interplay
Gary Kohanbash et al.
SEMINARS IN CANCER BIOLOGY (2012)
Accessory molecules for Toll-like receptors and their function
Clarissa C. Lee et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
Brandon W. Higgs et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
IRF8 and IRF3 cooperatively regulate rapid interferon-β induction in human blood monocytes
Peng Li et al.
BLOOD (2011)
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
Carmen Jeronimo et al.
EUROPEAN UROLOGY (2011)
PIASy Inhibits Virus-induced and Interferon-stimulated Transcription through Distinct Mechanisms
Toru Kubota et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Guanylate Binding Protein 4 Negatively Regulates Virus-Induced Type I IFN and Antiviral Response by Targeting IFN Regulatory Factor 7
Yu Hu et al.
JOURNAL OF IMMUNOLOGY (2011)
Ligand-Stimulated Downregulation of the Alpha Interferon Receptor: Role of Protein Kinase D2
Hui Zheng et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
miRNA-mediated feedback inhibition of JAK/STAT morphogen signalling establishes a cell fate threshold
Wan Hee Yoon et al.
NATURE CELL BIOLOGY (2011)
Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies
C. Cappelletti et al.
NEUROLOGY (2011)
Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis
Arpita Myles et al.
RHEUMATOLOGY (2011)
Type I interferon pathway in adult and juvenile dermatomyositis
Emily C. Baechler et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Systemic Sclerosis and Lupus Points in an Interferon-Mediated Continuum
Shervin Assassi et al.
ARTHRITIS AND RHEUMATISM (2010)
NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways
Jun Cui et al.
CELL (2010)
Recent findings on genetics of systemic autoimmune diseases
Angelica Delgado-Vega et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
The Ubiquitin E3 Ligase RAUL Negatively Regulates Type I Interferon through Ubiquitination of the Transcription Factors IRF7 and IRF3
Yanxing Yu et al.
IMMUNITY (2010)
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus
Cristiana Guiducci et al.
NATURE (2010)
Genetic susceptibility to systemic lupus erythematosus in the genomic era
Yun Deng et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Elevated Serum Interferon-α Activity in Juvenile Dermatomyositis Associations With Disease Activity at Diagnosis and After Thirty-Six Months of Therapy
Timothy B. Niewold et al.
ARTHRITIS AND RHEUMATISM (2009)
RNA recognition and signal transduction by RIG-I-like receptors
Mitsutoshi Yoneyama et al.
IMMUNOLOGICAL REVIEWS (2009)
Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response
Gillian I. Rice et al.
NATURE GENETICS (2009)
Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells
Giuseppe Mancuso et al.
NATURE IMMUNOLOGY (2009)
Association between IFN-alpha and primary Sjogren's syndrome
Lingyan Zheng et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2009)
Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus
Chaim O. Jacob et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response
Ying Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Two Further Cases of Spondyloenchondrodysplasia (SPENCD) With Immune Dysregulation
V. Navarro et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation
Ali Shilatifard
CURRENT OPINION IN CELL BIOLOGY (2008)
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood
Brian M. Feldman et al.
LANCET (2008)
Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1
Huazhang An et al.
NATURE IMMUNOLOGY (2008)
TRIM family proteins and their emerging roles in innate immunity
Keiko Ozato et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The future of biologic agents in the treatment of Sjogren's syndrome
Jiska M. Meijer et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2007)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
Roberto Baccala et al.
NATURE MEDICINE (2007)
Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125
Kei-ichiro Arimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Distinct expression pattern of IFN-α and TNF-α in juvenile idiopathic arthritis synovial tissue
M. Gattorno et al.
RHEUMATOLOGY (2007)
Pre-assembly of STAT4 with the human IFN-α-/β receptor-2 subunit is mediated by the STAT4 N-domain
Douglas R. Tyler et al.
MOLECULAR IMMUNOLOGY (2007)
SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production
Huazhang An et al.
IMMUNITY (2006)
MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: Association with muscle involvement
Kevin A. O'Connor et al.
CLINICAL IMMUNOLOGY (2006)
Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection
Yanick J. Crow et al.
NATURE GENETICS (2006)
Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus
Yanick J. Crow et al.
NATURE GENETICS (2006)
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome
JE Gottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
IRF family proteins and type I interferon induction in dendritic cells
P Tailor et al.
CELL RESEARCH (2006)
Cytoplasmic protein tyrosine phosphatases, regulation and function:: the roles of PTP1B and TC-PTP
A Bourdeau et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Activation of the type I interferon system in primary Sjogren's syndrome -: A possible etiopathogenic mechanism
U Båve et al.
ARTHRITIS AND RHEUMATISM (2005)
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis
J van Holten et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors
TH Chuang et al.
NATURE IMMUNOLOGY (2004)
PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity
B Liu et al.
NATURE IMMUNOLOGY (2004)
Interferons, interferon-like cytokines, and their receptors
S Pestka et al.
IMMUNOLOGICAL REVIEWS (2004)
Interferon-α and autoimmune thyroid disease
MF Prummel et al.
THYROID (2003)
DNA methylation and cancer therapy
M Szyf
DRUG RESISTANCE UPDATES (2003)
Suppressors of cytokine signalling (SOCS) in the immune system
WS Alexander
NATURE REVIEWS IMMUNOLOGY (2002)
Coordination of a transcriptional switch by HMGI(Y) acetylation
N Munshi et al.
SCIENCE (2001)
Ordered recruitment of chromatin modifying and general transcription factors to the IFN-β promoter
T Agalioti et al.
CELL (2000)
分享论文
